Loading clinical trials...
Loading clinical trials...
The investigators will evaluate the impact of dialysis modality (intermittent hemodialysis or continuous renal replacement therapy) in coagulation and platelet function in critically ill patients
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Seoul National University Hospital
NCT06889974 · Renal Replacement Therapy for Acute Kidney Injury in ICU
NCT06685367 · Acute Kidney Injury, Intensive Care, and more
NCT06014801 · Acute Kidney Injury Requiring Continuous Renal Replacement Therapy
NCT03541785 · Acute Kidney Injury, Renal Replacement Therapy, and more
NCT07312929 · Renal Dialysis, Renal Replacement Therapy, and more
Seoul National University Hospital
Seoul, Jongno-gu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions